Aaron Mitchell

@medscape.com coverage of our recent findings presented at the @ascocancer.bsky.social Quality Care Symposium. Oncologists who received industry payments are more likely to use aggressive end-of-life cancer care: www.medscape.com/viewarticle/...

Just finished presenting these new findings at #ASCOQLTY26 Industry payments to oncologists are associated with aggressive end-of-life care for patients with cancer.

I'll be presenting our latest this weekend at @ascocancer.bsky.social Quality Care Symposium! On the association between industry money to oncologists their delivery of lower-quality, more-aggressive end-of-life care @ryannipp.bsky.social @fumikochino.bsky.social www.asco.org/abstracts-pr...

“The contrast with financial toxicity is instructive. Financial toxicity, a term coined more than a decade earlier and serving as the explicit template for time toxicity, has never, to our knowledge, been used by a drug company to advertise a LOWER list price for a new drug.” 💯💯💯

Must-read perspective in Journal of Clinical Oncology @ascocancer.bsky.social on how the concept of “time toxicity” is being appropriated for industry aims (profits). I was not aware of this! Eye opening. ascopubs.org/doi/10.1200/...

“Patients come to oncology with fear and uncertainty. They are asking for judgment they can trust. That judgment should not be shaped by a meal, an honorarium, or a branded invitation.” Amazing editorial on our study from @sarojniraula.bsky.social ascopubs.org/doi/10.1200/...

Gender-affirming care saves lives, respects the rights of patients, and reflects that healthcare is supposed to be between providers and patients, not between providers and the Trump Administration. (1/3)

NEW: Draft white paper up on SSRN - "Reimagining FDA’s Corporate Funding: Pathways to Reform or Abolition of User Fees" FDA's corporate funding, aka "user fees," are not ancillary -- they have big implications for FDA policy & integrity. (1/x) papers.ssrn.com/sol3/papers....

"The only measures that have been shown to reduce COI to date are legislated policies, specifically those policies that ban or restrict gifts to doctors..." Agree with this perspective by Dr. Joel Lexchin. Disclosure is not enough! journals.sagepub.com/doi/full/10....

The actual harsh truth about MAHA is that it is an anti-vaxx, anti-science, pro-diarrhea conspiracy movement. It cloaks its arguments in abstractions about "big pharma" and "free speech" to generate *the exact op-ed The Atlantic keeps publishing*. Movements like this need to be fought, not placated.

Good reminder of how hard it is to access health insurance for people who are disabled by their conditions but in the waiting period for coverage for SSDI/Medicare. The mortality during the wait period for people with cancer (neoplasms) is nearly 40%. www.healthaffairs.org/doi/epdf/10....

Asking for help: are there any publicly available data sources on hospital surgical volume?

Negotiating prices at launch creates more equity among Medicare beneficiaries, ensuring that people who need a drug earlier in the product’s lifecycle are not disproportionately bearing the costs of a medicine. www.healthaffairs.org/content/fore...

Honestly, WTF.

"This study provides among the most rigorous evidence to date on receipt of optimal initial therapy [for cancer]...in a nationally representative sample of beneficiaries in MA vs traditional Medicare." Thank-you to our commentators for this kind review! jamanetwork.com/journals/jam...

1st firsthand experience with NHS today: 1) spent an entire day navigating a bureaucratic maze of separate labs, clinics, cash-pay-only pharmacies, and land-line-only phone consults 2) entire bill for same-day consult and Rx, without insurance = $20 Sounds about right

Medical device industry payments to physicians were associated with higher utilization of corresponding devices, with a stepwise increase in procedure volumes as payments rose. ja.ma/3RfJqjq

Coverage of our recent COI study presented at #ASCO26 @ascocancer.bsky.social, finding that oncologists increase cancer drug prescribing after receiving drug company bribes. (in print soon!) www.healthcare-brew.com/stories/phar...

Happening now!

ADA leaders were forcibly removed from their own meeting for sharing copies of an ADA OpEd critical of Jay Bhattacharya. Thanks to you it's now got >125,000 views. As CDC interim director, Jay also blocked publication of this paper because it showed that COVID vaccines work. You know what to do.

Nice editorial @thewonkologist.bsky.social & Dr. Nancy Keating about revisiting our priors re: Medicare Advantage for cancer care. While there is reason to be cautious and investigate, current data on MA vs traditional medicare in cancer is far from conclusive. ascopubs.org/doi/10.1200/...

I appreciate this @jama.com commentary by Knox and @asarpatwari.bsky.social. I'm among the skeptics of the 340B program as it currently operates, but it appears this proposed pilot would not address the major issues. jamanetwork.com/journals/jam...

Presenting our new study at #ASCO26 right now! Provider profits on cancer drugs have grown 4-fold to $40 billion in the last decade and a half. @ascocancer.bsky.social @mskcancercenter.bsky.social @hannahrabrams.bsky.social @nihcm.bsky.social

Presenting at #ASCO26 now! Our new study: Bribes from the drug industry can lead oncologists to use WORSE treatments (not just better ones) @ascocancer.bsky.social @mskcancercenter.bsky.social @dusetzinas.bsky.social @commonwealthfund.org @nihcm.bsky.social @arnoldventures.bsky.social

Farewell #ARM26! #ASCO26, see you in about 5 hours! @ascocancer.bsky.social @academyhealth.bsky.social

I'll be presenting new findings at 2:15 PT today at #ARM26! Our study measured provider profits on cancer drugs (profits have increased, a lot) This looks like a great session, including other new findings on cancer care in MA. See you in ballroom 6C! academyhealth.confex.com/academyhealt...

Excited to present preliminary results from a project that has been ongoing ~since I was a PhD student~ at today's late-breaking #ARM26 session — join us at 4p PT in rooms 613-614.

The webinar recording is now available, below. I'm also looking forward to presenting these findings on Medicare Advantage and cancer care at @academyhealth.bsky.social #ARM26, this weekend! cbiit.webex.com/recordingser...

Here’s how he blew off 19 kids killed by Covid in 1 month.